ReviewCells2025

Chimeric Autoantibody Receptor- and/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases.

Isidora Protić-Rosić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.